University of Huddersfield Honorary Award Goes to RSC’s First Woman President
News Sep 20, 2017 | Original story from the University of Huddersfield
Professor Lesley Yellowlees.
Professor Lesley Yellowlees will receive the award of Honorary Doctorate of the University for services to chemistry.
The first woman President of the Royal Society of Chemistry (RSC), Professor Lesley Yellowlees, will collect an honorary award from University of Huddersfield, which will be presented at the University’s November Award Ceremonies.
Professor Yellowlees completed both her BSc in Chemical Physics and her PhD at the University of Edinburgh. After completing research positions in Brisbane, Australia and Glasgow, she returned to an academic position in Edinburgh in 1986 and gained a personal chair in Inorganic Electrochemistry in 2005. She served as Head of the School of Chemistry at Edinburgh from 2005-10 and was Vice-Principal and Head of the College of Science and Engineering at the University of Edinburgh from 2011-17. She was the first woman to hold both these positions.
In 2012, she became the first woman President of the RSC, a post she held for two years.
Her academic interests include inorganic electrochemistry and spectroelectrochemistry, solar energy, the public engagement of science and the promotion of women in science.
She was awarded an MBE in 2005 for services to science and a CBE in 2014 for services to chemistry. She was elected as a Fellow of the Royal Society of Edinburgh in 2012 and an Honorary Fellow of the RSC in 2016.
This article has been republished from materials provided by the University of Huddersfield. Note: material may have been edited for length and content. For further information, please contact the cited source.
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV DrugNews
Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.READ MORE
Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain CancerNews
Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.READ MORE
New Drug Class: Potential Therapeutics for Alzheimer’s Disease?News
One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.READ MORE